Skip to content

The use of Auriculotherapy in the Treatment of smoking cessation

Use of Auriculotherapy combined with Conventional Treatment in smoking control: a clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5pgfy5j
Enrollment
Unknown
Registered
2025-11-24
Start date
2025-01-22
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use Cessation

Interventions

A randomized, single-blind, controlled clinical trial was conducted with 60 smokers who will receive care and monitoring at SECOPTT (Tobacco Control, Prevention, and Treatment Service) in Juiz de Fora
nicotine dependence using the Fagerström Nicotine Dependence Questionnaire
withdrawal symptoms using the Minnesota Nicotine Withdrawal Scale
anxiety and depression using the Hospital Anxiety and Depression Scale
physical activity level using the International Physical Activity Questionnaire
peak expiratory flow using the Peak Flow
physical fitness level using the Incremental Shuttle Walk Test
presence and intensity of pain using the Visual Analog Scale.

Sponsors

Universidade Federal de Juiz de Fora
Lead Sponsor
Universidade Federal de Juiz de Fora
Collaborator

Eligibility

Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Be 18 years of age or older; both genders; Smoker; Be enrolled in the Tobacco Control, Prevention, and Treatment Service (SECOPTT) in the city of Juiz de Fora, Minas Gerais; Express a desire to quit smoking; Be available to participate in the study

Exclusion criteria

Exclusion criteria: Presence of infection, inflammation, or injury to the auricle; Use of piercings or ear gauges (except regular earrings); Allergy to micropore; Pregnancy; Asthma and bronchitis; Cognitive difficulties that prevent data collection through assessment instruments

Design outcomes

Primary

MeasureTime frame
To evaluate the effects of auriculotherapy associated with conventional treatment in smoking control.

Secondary

MeasureTime frame
Before and after interventions, assess the following: Smoking abstinence rate (number of days without smoking), based on participant self-report. ;Nicotine dependence level, based on the Fagerström Nicotine Dependence Questionnaire (NFQ).;Withdrawal symptoms, based on the Minnesota Nicotine Withdrawal Scale.;Anxiety and depression levels, based on the Hospital Anxiety and Depression Scale (HAD).;Physical activity level, based on the International Physical Activity Questionnaire.;Physical fitness level, based on the Incremental Shuttle Walk Test (ISWT).;Peak expiratory flow, based on the Peak Flow.;Presence and intensity of pain (if any), based on the Visual Analog Scale (VAS), and its location on the body.;Check for correlation between assessment findings and conventional treatment combined with Auriculotherapy.

Countries

Brazil

Contacts

Public ContactElizângela Abreu

Universidade Federal de Juiz de Fora

eliz_nasa@ufjf.br+55-12-981476984

Outcome results

None listed

Source: REBEC (via WHO ICTRP)